vs
Immunovant, Inc.（IMVT）与西港燃料系统（WPRT）财务数据对比。点击上方公司名可切换其他公司
西港燃料系统的季度营收约是Immunovant, Inc.的1.5倍（$12.5M vs $8.4M），西港燃料系统净利率更高（-274.8% vs -899.0%，领先624.2%），Immunovant, Inc.同比增速更快（140.7% vs -11.4%），西港燃料系统自由现金流更多（$-6.4M vs $-59.8M）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
西港创新专注研发低碳替代燃料技术，帮助发动机使用压缩天然气、液化天然气、氢气以及填埋气等生物清洁能源运行。该公司发源于加拿大不列颠哥伦比亚省温哥华，总部也设立于此，同时在法国、瑞典、意大利、中国、澳大利亚和美国均设有运营机构。
IMVT vs WPRT — 直观对比
营收规模更大
WPRT
是对方的1.5倍
$8.4M
营收增速更快
IMVT
高出152.2%
-11.4%
净利率更高
WPRT
高出624.2%
-899.0%
自由现金流更多
WPRT
多$53.4M
$-59.8M
损益表 — Q4 FY2024 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $12.5M |
| 净利润 | $-75.3M | $-34.3M |
| 毛利率 | — | 6.7% |
| 营业利润率 | -896.2% | -8.1% |
| 净利率 | -899.0% | -274.8% |
| 营收同比 | 140.7% | -11.4% |
| 净利润同比 | -26.7% | -690.4% |
| 每股收益（稀释后） | $-0.50 | $-1.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTWPRT
| Q2 25 | — | $12.5M | ||
| Q3 24 | — | $4.9M | ||
| Q2 24 | — | $14.1M | ||
| Q1 24 | $8.4M | — | ||
| Q4 23 | $8.9M | — | ||
| Q3 23 | $3.6M | — | ||
| Q2 23 | $4.1M | — | ||
| Q1 23 | $3.5M | — |
净利润IMVTWPRT
| Q2 25 | — | $-34.3M | ||
| Q3 24 | — | $-3.9M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | $-75.3M | — | ||
| Q4 23 | $-51.4M | — | ||
| Q3 23 | $-58.7M | — | ||
| Q2 23 | $-73.9M | — | ||
| Q1 23 | $-59.4M | — |
毛利率IMVTWPRT
| Q2 25 | — | 6.7% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 16.7% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
营业利润率IMVTWPRT
| Q2 25 | — | -8.1% | ||
| Q3 24 | — | -43.9% | ||
| Q2 24 | — | -54.9% | ||
| Q1 24 | -896.2% | — | ||
| Q4 23 | -576.8% | — | ||
| Q3 23 | -1629.6% | — | ||
| Q2 23 | -1819.1% | — | ||
| Q1 23 | -1736.3% | — |
净利率IMVTWPRT
| Q2 25 | — | -274.8% | ||
| Q3 24 | — | -79.3% | ||
| Q2 24 | — | 41.2% | ||
| Q1 24 | -899.0% | — | ||
| Q4 23 | -575.6% | — | ||
| Q3 23 | -1642.3% | — | ||
| Q2 23 | -1818.9% | — | ||
| Q1 23 | -1707.8% | — |
每股收益（稀释后）IMVTWPRT
| Q2 25 | — | $-1.98 | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | — | $0.34 | ||
| Q1 24 | $-0.50 | — | ||
| Q4 23 | $-0.36 | — | ||
| Q3 23 | $-0.45 | — | ||
| Q2 23 | $-0.57 | — | ||
| Q1 23 | $-0.46 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $6.1M |
| 总债务越低越好 | — | $977.0K |
| 股东权益账面价值 | $617.8M | $108.9M |
| 总资产 | $666.4M | $272.1M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资IMVTWPRT
| Q2 25 | — | $6.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $635.4M | — | ||
| Q4 23 | $690.9M | — | ||
| Q3 23 | $269.9M | — | ||
| Q2 23 | $330.0M | — | ||
| Q1 23 | $376.5M | — |
总债务IMVTWPRT
| Q2 25 | — | $977.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
股东权益IMVTWPRT
| Q2 25 | — | $108.9M | ||
| Q3 24 | — | $149.3M | ||
| Q2 24 | — | $151.5M | ||
| Q1 24 | $617.8M | — | ||
| Q4 23 | $679.3M | — | ||
| Q3 23 | $251.8M | — | ||
| Q2 23 | $299.9M | — | ||
| Q1 23 | $362.5M | — |
总资产IMVTWPRT
| Q2 25 | — | $272.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $666.4M | — | ||
| Q4 23 | $711.4M | — | ||
| Q3 23 | $292.1M | — | ||
| Q2 23 | $351.2M | — | ||
| Q1 23 | $405.8M | — |
负债/权益比IMVTWPRT
| Q2 25 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $-5.6M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $-6.4M |
| 自由现金流率自由现金流/营收 | -714.4% | -51.6% |
| 资本支出强度资本支出/营收 | 1.8% | 6.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-214.6M | — |
8季度趋势，按日历期对齐
经营现金流IMVTWPRT
| Q2 25 | — | $-5.6M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | $-59.7M | — | ||
| Q4 23 | $-47.1M | — | ||
| Q3 23 | $-60.1M | — | ||
| Q2 23 | $-47.4M | — | ||
| Q1 23 | $-55.8M | — |
自由现金流IMVTWPRT
| Q2 25 | — | $-6.4M | ||
| Q3 24 | — | $-11.9M | ||
| Q2 24 | — | $262.0K | ||
| Q1 24 | $-59.8M | — | ||
| Q4 23 | $-47.2M | — | ||
| Q3 23 | $-60.1M | — | ||
| Q2 23 | $-47.4M | — | ||
| Q1 23 | $-55.8M | — |
自由现金流率IMVTWPRT
| Q2 25 | — | -51.6% | ||
| Q3 24 | — | -243.4% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | -714.4% | — | ||
| Q4 23 | -528.7% | — | ||
| Q3 23 | -1682.4% | — | ||
| Q2 23 | -1166.4% | — | ||
| Q1 23 | -1604.0% | — |
资本支出强度IMVTWPRT
| Q2 25 | — | 6.6% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | 1.8% | — | ||
| Q4 23 | 1.5% | — | ||
| Q3 23 | 1.0% | — | ||
| Q2 23 | 1.1% | — | ||
| Q1 23 | 0.7% | — |
现金转化率IMVTWPRT
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.26× | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
